A Phase II trial of the Raf Kinase and Receptor Tyrosine Kinase Inhibitor Sorafenib in Children and Young Adults with Relapsed/Refractory Rhabdomyosarcomas Wilms Tumor Hepatocellular Carcinoma and Papillary Thyroid Carcinoma
-
- STATUS
- Not Recruiting
Updated on 19 February 2024
Summary
No Description Available
Description
No Description Available
Details
| Condition | Kidney Cancer,Thyroid Cancer,Rhabdomyosarcoma,Wilms' Tumor |
|---|---|
| Age | 2years - 30years |
| Clinical Study Identifier | TX3778 |
| Last Modified on | 19 February 2024 |
How understandable was the trial content above?
Hard to understand
Easy to understand
Similar trials to consider
Loading...
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.